Encapsulation of anti-carbonic anhydrase IX antibody in hydrogel microspheres for tumor targeting
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F16%3AN0000051" target="_blank" >RIV/00209805:_____/16:N0000051 - isvavai.cz</a>
Result on the web
<a href="http://www.tandfonline.com/doi/full/10.1080/14756366.2016.1177523" target="_blank" >http://www.tandfonline.com/doi/full/10.1080/14756366.2016.1177523</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/14756366.2016.1177523" target="_blank" >10.1080/14756366.2016.1177523</a>
Alternative languages
Result language
angličtina
Original language name
Encapsulation of anti-carbonic anhydrase IX antibody in hydrogel microspheres for tumor targeting
Original language description
Encapsulation is a well-established method of biomaterial protection, controlled release, and efficient delivery. Here we evaluated encapsulation of monoclonal antibody M75 directed to tumor biomarker carbonic anhydrase IX (CA IX) into alginate microbeads (SA-beads) or microcapsules made of sodium alginate, cellulose sulfate, and poly(methylene-co-guanidine) (PMCG). M75 antibody release was quantified using ELISA and its binding properties were assessed by immunodetection methods. SA-beads showed rapid M75 antibody release in the first hour, followed by steady release during the whole experiment of 7 days. In contrast, the M75 release from PMCG capsules was gradual, reaching the maximum concentration on the 7th day. The release was more efficient at pH 6.8 compared to pH 7.4. The released antibody could recognize CA IX, and target the CA IX-positive cells in 3D spheroids. In conclusion, SA-beads and PMCG microcapsules can be considered as promising antibody reservoirs for targeting of cancer cells.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/LO1413" target="_blank" >LO1413: RECAMO2020</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Enzyme Inhibition and Medicinal Chemistry
ISSN
1475-6366
e-ISSN
—
Volume of the periodical
31
Issue of the periodical within the volume
Sup1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
110-118
UT code for WoS article
000389344900013
EID of the result in the Scopus database
—